COMPOSITION AND DOSAGE FORM FOR SUSTAINED EFFECT OF LEVODOPA
摘要
The present invention encompasses compositions for the treatment of Parkinson's disease comprising a therapeutically effective amount of levodopa or a metabolic precursor thereof and at least one dopamine transport inhibitor in sufficient amount to decrease dopamine degradation, wherein the dopamine transport inhibitor is administered to avid dyskinesia.
申请公布号
WO2005042101(A8)
申请公布日期
2006.10.19
申请号
WO2004US34121
申请日期
2004.10.14
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;FLASHNER-BARAK, MOSHE;LERNER, E., ITZHAK;ROSENBERGER, VERED
发明人
FLASHNER-BARAK, MOSHE;LERNER, E., ITZHAK;ROSENBERGER, VERED